Susceptibility to miltefosine in brazilian clinical isolates of Leishmania (Viannia) braziliensis (2017)
- Authors:
- USP affiliated authors: YASUNAKA, JENICER KAZUMI UMADA YOKOYAMA - ICB ; ULIANA, SILVIA RENI BORTOLIN - ICB
- Unidade: ICB
- DOI: 10.4269/ajtmh.16-0811
- Assunto: PARASITOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título: American Journal of Tropical Medicine and Hygiene
- ISSN: 1476-1645
- Volume/Número/Paginação/Ano: v. 96, n. 3, p. 656-659, 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ESPADA, Caroline R. et al. Susceptibility to miltefosine in brazilian clinical isolates of Leishmania (Viannia) braziliensis. American Journal of Tropical Medicine and Hygiene, v. 96, n. 3, p. 656-659, 2017Tradução . . Disponível em: https://doi.org/10.4269/ajtmh.16-0811. Acesso em: 27 fev. 2026. -
APA
Espada, C. R., Ribeiro-Dias, F., Dorta, M. L., Pereira, L. I. de A., Carvalho, E. M. de, Machado, P. R., et al. (2017). Susceptibility to miltefosine in brazilian clinical isolates of Leishmania (Viannia) braziliensis. American Journal of Tropical Medicine and Hygiene, 96( 3), 656-659. doi:10.4269/ajtmh.16-0811 -
NLM
Espada CR, Ribeiro-Dias F, Dorta ML, Pereira LI de A, Carvalho EM de, Machado PR, Schriefer A, Yokoyama-Yasunaka JKU, Coelho AC, Uliana SRB. Susceptibility to miltefosine in brazilian clinical isolates of Leishmania (Viannia) braziliensis [Internet]. American Journal of Tropical Medicine and Hygiene. 2017 ; 96( 3): 656-659.[citado 2026 fev. 27 ] Available from: https://doi.org/10.4269/ajtmh.16-0811 -
Vancouver
Espada CR, Ribeiro-Dias F, Dorta ML, Pereira LI de A, Carvalho EM de, Machado PR, Schriefer A, Yokoyama-Yasunaka JKU, Coelho AC, Uliana SRB. Susceptibility to miltefosine in brazilian clinical isolates of Leishmania (Viannia) braziliensis [Internet]. American Journal of Tropical Medicine and Hygiene. 2017 ; 96( 3): 656-659.[citado 2026 fev. 27 ] Available from: https://doi.org/10.4269/ajtmh.16-0811 - Discovery of synthetic Leishmania Inhibitors by screening of a 2-arylbenzothiophene library
- Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: validation of luciferase as a quantitative tool
- Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial
- A dysflagellar mutant of Leishmania (Viannia) braziliensis isolated from a cutaneous leishmaniasis patient
- Combination therapy with Tamoxifen and Amphotericin B in experimental cutaneous Leishmaniasis
- In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B
- Topical tamoxifen in the therapy of cutaneous leishmaniasis
- Antileishmanial activity of the estrogen receptor modulator raloxifene
- Low plasma lipids are associated with relapsing and lethal Visceral Leishmaniasis in HIV-infected patients
- Leishmania is not prone to develop resistance to tamoxifen
Informações sobre o DOI: 10.4269/ajtmh.16-0811 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
